The FDA Hasn’t Inspected This Drug Factory After 7 Recalls for the Same Flaw, 1 Potentially Deadly
So the danger was obvious in May, when Indian drugmaker Glenmark Pharmaceuticals recalled nearly 47 million capsules for a dire flaw: The extended-release medication wasn’t dissolving properly ...
Indian drugmakers Aurobindo, Glenmark and Zydus have issued separate sweeping drug recalls over issues pertaining to impurities and labeling. The product pulls were reported in a recent edition of ...
Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the launch of lacosamide oral solution, 10 mg/mL. Glenmark’s lacosamide oral solution, 10 mg/mL is bioequivalent and therapeutically equivalent ...
Glenmark Pharmaceuticals reported a second-quarter profit on Thursday, helped by strong demand for its drugs that treat long-term illnesses. India's Glenmark Pharma posts Q2 profit on strong ...
.In December 2024:- AstraZeneca- A Phase II, Randomized, Double-blind, Single-dose, Placebo-controlled, 3-Period, 3-Treatment, Crossover, Multicenter Study to Compare the Bronchodilatory Effect ...
The FDA hasn’t inspected this drug factory after 7 recalls for the same flaw, 1 potentially deadly
This article originally appeared on ProPublica. ProPublica is a Pulitzer Prize-winning investigative newsroom. Sign up for The Big Story newsletter to receive stories like this one in your inbox.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback